Word

ACLARIS THERAPEUTICS

Status

Pending

Status Code

641

Status Date

Tuesday, May 7, 2024

Serial Number

98161577

Mark Type

3

Filing Date

Friday, September 1, 2023

Trademark Owner History

Aclaris Therapeutics, Inc.

Classifications

5 anti-inflammatories; pharmaceutical preparations for dermatological, gastro-intestinal, autoimmune, immune system, skin, oncological, immuno-inflammatory, musculoskeletal, respiratory, central nervous system, kidney diseases, cardiovascular, endocrine, tissue and organ, ocular, ophthalmological, metabolic, genitourinary, urological, hepatic, otolaryngology, hematologic, genetic, and bone diseases and disorders; pharmaceutical preparations for the treatment of transplant rejection, graft-versus-host disease, vasculitis, myositis, myopathies, diabetes, allergies, asthma, and hair loss

The mark consists of lower case letters "ACLARIS" centered over smaller capital letters "THERAPEUTICS," which are placed over on the right side of a partial circle design comprised of four segmented curved lines.
Color is not claimed as a feature of the mark.

Trademark Events

Sep 5, 2023

New Application Entered

Sep 28, 2023

Notice Of Design Search Code E-Mailed

Nov 2, 2023

Teas Change Of Owner Address Received

Sep 27, 2023

New Application Office Supplied Data Entered

Nov 2, 2023

Teas Change Of Correspondence Received

Nov 2, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

May 7, 2024

Non-Final Action Written

May 7, 2024

Notification Of Non-Final Action E-Mailed

May 7, 2024

Non-Final Action E-Mailed

Apr 30, 2024

Assigned To Examiner